Equity Research, Broker Reports, and media content on DBV TECHNOLOGIES SA

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about DBV TECHNOLOGIES SA
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on DBV TECHNOLOGIES SA. We currently have 2 research reports from 1 professional analysts.

Date Source Announcement
17Nov16 06:30 GNW DBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis
10Nov16 06:30 GNW DBV Technologies to Attend Upcoming Investor Conferences
08Nov16 06:30 GNW DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients
03Nov16 06:31 GNW DBV Technologies Reports September 30, 2016 Cash Position
26Oct16 09:30 GNW DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology
24Oct16 09:30 GNW DBV Technologies: Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut
21Sep16 06:30 GNW DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow's Milk Protein Allergy
  • Frequency of research reports


  • Research reports on


  • Providers covering


Latest Content

View the latest research, videos, and podcasts for this company.